Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity.
Adipocytes
/ cytology
Adipose Tissue, Brown
/ metabolism
Animals
Antioxidants
/ metabolism
Blood Glucose
/ metabolism
Calorimetry
Diabetes Mellitus
/ metabolism
Disease Models, Animal
Glucose
/ metabolism
Homeostasis
Hyperinsulinism
/ metabolism
Hyperphagia
/ metabolism
Insulin
/ metabolism
Insulin Resistance
Leptin
/ metabolism
Lipodystrophy
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Obesity, Morbid
/ complications
Receptor, Insulin
/ genetics
Acetovanillone
Adipocyte
Adipocyte quantification
Adipocyte-specific
Adipose tissue
Antioxidants
Apocynin
CreERT2
Diet-induced obesity
Fat
Hyperglycaemia
Hyperinsulinaemic–euglycaemic clamp
Hyperphagia
Insulin receptor
Insulin resistance
Leptin deficiency
Lipolysis
N-acetylcysteine
Obesity resistance
Polydipsia obesity
Tamoxifen
Type 2 diabetes
iFIRKO
ob/ob
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
15
02
2019
accepted:
16
05
2019
pubmed:
17
7
2019
medline:
10
7
2020
entrez:
17
7
2019
Statut:
ppublish
Résumé
In the context of diabetes, the health benefit of antioxidant treatment has been widely debated. In this study, we investigated the effect of antioxidant treatment during the development of insulin resistance and hyperphagia in obesity and partial lipodystrophy. We studied the role of antioxidants in the regulation of insulin resistance using the tamoxifen-inducible fat-specific insulin receptor knockout (iFIRKO) mouse model, which allowed us to analyse the antioxidant's effect in a time-resolved manner. In addition, leptin-deficient ob/ob mice were used as a hyperphagic, chronically obese and diabetic mouse model to validate the beneficial effect of antioxidants on metabolism. Acute induction of insulin receptor knockout in adipocytes changed the substrate preference to fat before induction of a diabetic phenotype including hyperinsulinaemia and hyperglycaemia. In healthy chow-fed animals as well as in morbidly obese mice, this diabetic phase could be reversed within a few weeks. Furthermore, after the induction of insulin receptor knockout in mature adipocytes, iFIRKO mice were protected from subsequent obesity development through high-fat diet feeding. By genetic tracing we show that the persistent fat mass loss in mice after insulin receptor knockout in adipocytes is not caused by the depletion of adipocytes. Treatment of iFIRKO mice with antioxidants postponed and reduced hyperglycaemia by increasing insulin sensitivity. In ob/ob mice, antioxidants rescued both hyperglycaemia and hyperphagia. We conclude that fat mass reduction through insulin resistance in adipocytes is not reversible. Furthermore, it seems unlikely that adipocytes undergo apoptosis during the process of extreme lipolysis, as a consequence of insulin resistance. Antioxidants have a beneficial health effect not only during the acute phase of diabetes development, but also in a temporary fashion once chronic obesity and diabetes have been established.
Identifiants
pubmed: 31309261
doi: 10.1007/s00125-019-4937-7
pii: 10.1007/s00125-019-4937-7
pmc: PMC6805816
doi:
Substances chimiques
Antioxidants
0
Blood Glucose
0
Insulin
0
Leptin
0
Receptor, Insulin
EC 2.7.10.1
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2094-2105Références
Mol Cell. 1998 Nov;2(5):559-69
pubmed: 9844629
Biochim Biophys Acta. 2010 Mar;1801(3):209-14
pubmed: 19948243
J Clin Invest. 2005 Mar;115(3):703-10
pubmed: 15711637
Eur J Immunol. 2007 Jan;37(1):43-53
pubmed: 17171761
Handb Exp Pharmacol. 2019;251:37-54
pubmed: 30027460
Nat Rev Mol Cell Biol. 2019 Apr;20(4):242-258
pubmed: 30610207
Dose Response. 2014 Jan 31;12(2):288-341
pubmed: 24910588
Cell Metab. 2008 Jan;7(1):45-56
pubmed: 18177724
Genes Dev. 1998 Oct 15;12(20):3168-81
pubmed: 9784492
J Cell Physiol. 1987 Apr;131(1):64-73
pubmed: 3032995
Diabetes. 2017 Aug;66(8):2072-2081
pubmed: 28476930
J Ethnopharmacol. 2018 Jan 10;210:275-286
pubmed: 28859934
Cell Metab. 2017 Feb 7;25(2):448-462
pubmed: 28065828
J Clin Invest. 2004 Dec;114(12):1752-61
pubmed: 15599400
Diabetes Care. 2013 Nov;36(11):3821-42
pubmed: 24107659
Nat Metab. 2019 Mar;1(3):334-339
pubmed: 32661510
J Agric Food Chem. 2016 Nov 23;64(46):8857-8865
pubmed: 27792335
Mol Cell Pediatr. 2014 Dec;1(1):3
pubmed: 26567097
Diabetes. 2016 Aug;65(8):2187-200
pubmed: 27207510
J Clin Invest. 1996 Jun 15;97(12):2859-65
pubmed: 8675698
Diabetes. 1995 Aug;44(8):863-70
pubmed: 7621989
Carcinogenesis. 1985 Dec;6(12):1735-45
pubmed: 3905042
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
PLoS One. 2016 Jan 29;11(1):e0148115
pubmed: 26824477
Nat Med. 2014 Jul;20(7):709-11
pubmed: 24999941
Cell Metab. 2018 Oct 2;28(4):644-655.e4
pubmed: 30033199
Eur J Endocrinol. 2002 Oct;147(4):435-41
pubmed: 12370103
Nat Med. 2005 Jul;11(7):797-803
pubmed: 15965483
Lancet. 2002 Jul 6;360(9326):23-33
pubmed: 12114037
N Engl J Med. 2015 Jan 1;372(1):48-54
pubmed: 25551525
Nature. 1997 Jun 26;387(6636):903-8
pubmed: 9202122
Gastroenterology. 1998 Apr;114(4):764-74
pubmed: 9516397
J Physiol. 2018 Oct;596(19):4597-4609
pubmed: 30089335
Molecules. 2013 Mar 01;18(3):2821-39
pubmed: 23455672
Science. 2004 May 28;304(5675):1325-8
pubmed: 15166380
Mediators Inflamm. 2008;2008:106507
pubmed: 19096513
J Ethnopharmacol. 2000 Jul;71(1-2):23-43
pubmed: 10904144
Mech Ageing Dev. 2010 Apr;131(4):276-86
pubmed: 20307566
Diabetologia. 1978 Mar;14(3):141-8
pubmed: 350680